86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02023450 (ClinicalTrials.gov)	December 2013	23/12/2013	Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension		Pulmonary Arterial Hypertension	Drug: saquinavir and ritonavir	The Third Xiangya Hospital of Central South University	Xiangya Hospital of Central South University	Recruiting	18 Years	60 Years	Both	20	Phase 0	China
2	NCT01251848 (ClinicalTrials.gov)	January 2011	1/12/2010	Drug Interaction Between Ritonavir And Sitaxsentan	A Phase 1, Open Label, Randomized, Multiple Dose Study To Assess The Two-Way Drug Interaction Between Sitaxsentan And Low Dose Ritonavir In Healthy Subjects	Pulmonary Arterial Hypertension	Drug: Sitaxentan;Drug: Ritonavir;Drug: Sitaxsentan	Pfizer	NULL	Withdrawn	21 Years	55 Years	Both	0	Phase 1	NULL